What happens to unhoused people who get COVID-19?
Articles on Health care costs
Displaying 21 - 40 of 51 articles
Hispanics born in the US have worse health outcomes than Hispanics in the US who were born in countries from which they emigrated.
Reopening state economies too soon risks a second wave of the pandemic, and a surge in medical costs. Anyone who pays insurance premiums and taxes will be picking up the tab.
In the UK, nobody collects patients’ insurance information or credit card details. There’s simply no charge for services, including doctor visits, ambulances and hospitalizations.
Would you buy a pair of shoes without knowing the price? Consumers have bought medical care from hospitals for years without knowing the costs, but new regulations will change that.
There’s a very simple way to give Medicare to all: delete six words from the legislation that created the program in 1965.
Presidential candidates have been proposing plans to expand health coverage, lower prescription drug costs and make hospital bills more transparent. But few get to the real problem. Here’s why.
President Trump has been backing transparency in hospital pricing so that consumers can compare prices. But will that help when the real deals are done in secret?
How willing are people to accept medical care from a robot or an automated system? It depends on the procedure – and the price.
Electronic medical records were supposed to improve health care. Are they doing that? Two doctors describe the problems.
A cancer diagnosis is one of the scariest of all. The pain and fear are worsened by a confusing landscape of bills, opaque billing systems and changing insurance rules, rates and reimbursements.
The president should use his penchant for shaking up the status quo to tackle the genuine crisis in health care.
The Trump administration’s latest effort to undermine the Affordable Care Act is the expansion of short-term insurance plans. But these shorter plans are also short on real benefits.
A routine childbirth proves expensive and complicated. Insurance company adjustments, inconsistent billing and mystery costs flummoxed even a health policy expert and his wife, a teacher.
Corruption in Nigeria’s health sector can be eliminated by the implementation of a few simple strategies.
Noted physician and author Atul Gawande was named CEO of a new health care venture aimed at cutting costs and improving care. But the most important man to keep an eye on in this effort isn’t Gawande. It’s the middleman.
Who’s really benefiting from a health care system that provides free or low-cost plastic surgeries for the poor?
The rising costs of generic drugs have led to outcries. In a search for solutions, four hospital systems are proposing to make drugs on their own. Could their idea work?
Poor diet kills hundreds of thousands per year. If we want to achieve meaningful health care reform, we need to address our nation’s nutrition crisis.
To work out how to reduce the out-of-pocket costs for specialist care, we first need to identify why they are so high.
Top contributors
-
Professor of Gerontology, UMass Boston
-
Senior Research Fellow and Lecturer of Gerontology, UMass Boston
-
Associate Professor of Public Health, The Ohio State University
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Assistant Professor of Marketing, Indiana University
-
Professor of Health Finance, Weatherhead School of Management & School of Medicine, Case Western Reserve University
-
Professor of Economics, UMass Amherst
-
Associate Professor of Marketing, Texas Tech University
-
Associate Professor, Neurology, University of Florida
-
Assistant Professor of Health Policy and Managment, School of Public Health, Texas A&M University
-
Distinguished Professor of Sociology and Demography, Penn State
-
Professor of Surgery, Division of Public Health Sciences, Washington University in St. Louis
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Professor and Chair of Health Economics, Rice University
-
Professor of Pharmacy, Queensland University of Technology